companydata.dkcompanydata.dk

ASTRAZENECA A/S: Financial statements 2024

CVR: 55742928

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

ASTRAZENECA A/S (CVR 55742928) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 475,073,000 and a net result of DKK 6,241,000 compared with DKK 16,214,000 the year before. That is an increase of 21.5% compared with the year before. The profit margin was 1.3%. Equity in the 2024 report amounted to DKK 202,628,000. The solvency ratio was 67.1%. The company had 126 employees in the financial year.

Revenue
DKK 475,073,000
Gross Profit
DKK 188,709,000
Profit/Loss
DKK 6,241,000
Equity
DKK 202,628,000
Total Assets
DKK 302,098,000
Employees
126

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024475.1 mio.188.7 mio.6.2 mio.202.6 mio.126
2023391.1 mio.168.5 mio.16.2 mio.196.4 mio.110
2022395.5 mio.137.3 mio.11.8 mio.180.2 mio.89
2021259.6 mio.116.4 mio.6.5 mio.168.4 mio.78
2020256.2 mio.108 mio.5.6 mio.161.9 mio.71

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

ASTRAZENECA A/S wins public contractNov 29, 2024

ASTRAZENECA A/S has won the tender "Amgros 2025 1.1163.a" issued by Amgros I/S worth 1,644,000,000 DKK.

ASTRAZENECA A/S wins public contractNov 26, 2024

ASTRAZENECA A/S has won the tender "Amgros 2025 1.709.a" issued by Amgros I/S worth 145,756,745 DKK.

ASTRAZENECA A/S wins public contractNov 25, 2024

ASTRAZENECA A/S has won the tender "Amgros 2025 2.213.a" issued by Amgros I/S worth 18,145,464 DKK.

ASTRAZENECA A/S wins public contractNov 19, 2024

ASTRAZENECA A/S has won the tender "Amgros 2025 1.356.a" issued by Amgros I/S worth 4,530,400,000 DKK.

ASTRAZENECA A/S wins public contractOct 24, 2024

ASTRAZENECA A/S has won the tender "Amgros 2025 1.700.a" issued by Amgros I/S worth 313,301,544 DKK.

ASTRAZENECA A/S: The 2023 annual report is outJul 2, 2024

ASTRAZENECA A/S has published its annual report for 2023. Revenue came to DKK 391,141,000, and the net result was DKK 16,214,000.

ASTRAZENECA A/S wins public contractMay 7, 2024

ASTRAZENECA A/S has won the tender "Amgros 2024 1.167.a" issued by Amgros I/S worth 291,550,000 DKK.

ASTRAZENECA A/S wins public contractApr 26, 2024

ASTRAZENECA A/S has won the tender "Amgros 2024 1.971.a" issued by Amgros I/S worth 327,000,000 DKK.

About ASTRAZENECA A/S

ASTRAZENECA A/S is a Danish company of the type Aktieselskab based in København V, founded in 1943. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ASTRA DANMARK A/S and ASTRA-GRUPPEN A/S. The management consists of Christof Josef Bischoff. The board consists of Emelie Karin Susanne Antoni (chair), Charlotte Ivang Ladefoged, Christof Josef Bischoff and Erik Jesper Bergkvist. The company is owned by AstraZeneca Continent BV and AstraZeneca AB. The company has 122 employees (2026). In 2025, the company reported revenue of DKK 630,320,000 and a net result of DKK 24,203,000 compared with DKK 6,241,000 the year before. Equity in the 2025 report amounted to DKK 226,831,000.

Source: annual report 2025, Danish Business Authority